WATCH NOW
Solid Biosciences Webinar | April 2025
On April 15, 2025, Matthew Harmelink, MD, Therapeutic Head of Neuromuscular at Solid Biosciences and child neurologist with expertise in neuromuscular and neurogenetic disorders will talk about Friedreich’s ataxia (FA), the science behind gene therapy and the FALCON study, Solid’s unique gene therapy program for FA (SGT-212).
